Gilotrif 20 mg/1

Gilotrif 20 mg tablets are a prescription medication used to treat certain types of cancer. This film-coated tablet is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. in the USA.

Gilotrif 20 mg tablets are typically used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic markers. Afatinib, the active ingredient, is designed to target and inhibit certain proteins that contribute to cancer cell growth. Patients should consult their healthcare provider to determine if this medication is suitable for their condition.

Common effects of Gilotrif 20 mg tablets may include skin rash, diarrhea, and nausea. Some users might experience appetite loss or fatigue. These effects can vary in intensity and duration among individuals. It is important to monitor any persistent or severe symptoms and discuss them with a healthcare professional.

Gilotrif 20 mg tablets should be handled with care and stored as directed. This medication is intended for oral use only. Patients should follow their healthcare provider's instructions regarding dosage and administration. It is crucial to inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Gilotrif 20 mg tablets may interact with certain medications, including those that affect liver enzymes. Alcohol consumption should be avoided while taking this medication. Patients should also be cautious with other medications that may cause similar side effects, such as gastrointestinal issues or skin reactions.